MYOV—Sumitovant will have a 66% equity stake if the 10b5-1 buyback is completed in full. I’m unclear how that puts Sumitovant in a better position to act than the 53% stake they already had.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”